Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis
1 other identifier
observational
30
1 country
1
Brief Summary
This study aims to evaluate the tumor deposits in colorectal cancer and its prognostic value in survival and metastasis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 13, 2025
CompletedFirst Posted
Study publicly available on registry
March 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedMarch 19, 2025
March 1, 2025
3 years
March 13, 2025
March 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Patients' overall survival
Patients' overall survival (OS) is defined as from colorectal cancer (CRC) diagnosis to death.
2 years postoperatively
Secondary Outcomes (1)
Distant metastasis
2 years postoperatively
Study Arms (1)
Therapeutic resection group
Patients with colorectal cancer underwent therapeutic resection with pathologically positive tumor deposits (TDs) to determine distant metastasis occurrence and the effect of TDs on survival.
Interventions
Patients with colorectal cancer underwent therapeutic resection with pathologically positive tumor deposits (TDs) to determine distant metastasis occurrence and the effect of TDs on survival.
Eligibility Criteria
This prospective and retrospective study will be conducted on 30 patients with colorectal cancer.
You may qualify if:
- Age above 18 years old.
- Both sexes.
- All Colorectal cancer patients From Stage I to III Colorectal cancer with pathologically positive Tumor deposits.
You may not qualify if:
- Patient took neoadjuvant therapy.
- No information available on tumor deposits.
- Colorectal cancer is not the only primary cancer.
- Patients with incomplete information about follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minia University
Minya, 61611, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of General Surgery, Faculty of Medicine, Minia University, Minia, Egypt.
Study Record Dates
First Submitted
March 13, 2025
First Posted
March 19, 2025
Study Start
August 1, 2022
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
March 19, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.